CYP2C19*2polymorphism is associated with increased survival in breast cancer patients using tamoxifen
出版年份 2010 全文链接
标题
CYP2C19*2polymorphism is associated with increased survival in breast cancer patients using tamoxifen
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 11, Issue 10, Pages 1367-1375
出版商
Future Medicine Ltd
发表日期
2010-11-04
DOI
10.2217/pgs.10.112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies
- (2010) B. H. Ch. Stricker et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer
- (2010) Vincent O. Dezentjé et al. JOURNAL OF CLINICAL ONCOLOGY
- Significant Effect of Polymorphisms inCYP2D6andABCC2on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients
- (2010) Kazuma Kiyotani et al. JOURNAL OF CLINICAL ONCOLOGY
- The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users
- (2009) Monique J. Bijl et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment
- (2009) T. Ramón y Cajal et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen
- (2009) Masatsugu Okishiro et al. CANCER
- The Rotterdam Study: 2010 objectives and design update
- (2009) Albert Hofman et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genotype-guided tamoxifen therapy: time to pause for reflection?
- (2009) Timothy L Lash et al. LANCET ONCOLOGY
- CYP2C19*17 is associated with decreased breast cancer risk
- (2008) Christina Justenhoven et al. BREAST CANCER RESEARCH AND TREATMENT
- Impaired Tamoxifen Metabolism Reduces Survival in Familial Breast Cancer Patients
- (2008) W. G. Newman et al. CLINICAL CANCER RESEARCH
- Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
- (2008) V. O. Dezentje et al. CLINICAL CANCER RESEARCH
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
- (2008) Henrike E. Karim-Kos et al. EUROPEAN JOURNAL OF CANCER
- Proton pump inhibitors: an update of their clinical use and pharmacokinetics
- (2008) Shaojun Shi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
- (2008) M C Rebsamen et al. PHARMACOGENOMICS JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now